|Bid||0.8910 x 1000|
|Ask||0.9100 x 1000|
|Day's Range||0.8703 - 0.9319|
|52 Week Range||0.4700 - 2.5500|
|Beta (5Y Monthly)||1.57|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||May 12, 1980|
|1y Target Est||N/A|
Detroit, Michigan--(Newsfile Corp. - May 6, 2021) - AIkido Pharma Inc. (NASDAQ:AIKI) will be presenting at the Benzinga Global Small Cap Conference taking place on May 13-14, 2021. We invite our shareholders and all interested parties to explore investment opportunities within the global small cap space.Sign up to get a free spectator pass for the event: https://www.benzinga.com/events/small-cap/global/About the Benzinga Global Small Cap ConferenceThe Benzinga Global Small Cap Conference bridges the gap between Small Cap ...
AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Rachel Yehuda appeared at SXSW for a panel discussion entitled Psychedelics: Rewiring Mental Health Care. The Company is a proud supporter of Dr. Yehuda's research. The SXSW panel discussed ongoing clinical trials, recent medical discoveries, and how psilocybin may be part of the solution to our mental health crisis. The session is available on demand at the SXSW website.
AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Matthew Frieman has joined the Company's Scientific Advisory Board.